Skip to content

Common Stock at other companies

Indivior Pharmaceuticals, Inc.
 logo
Indivior Pharmaceuticals, Inc. INDV
$0-100%
Catalyst Pharmaceutical logo
Catalyst PharmaceuticalCPRX
$122K0.0%
Avanos Medical logo
Avanos MedicalAVNS
300M0.0%
Pacira BioSciences, Inc. logo
Pacira BioSciences, Inc.PCRX
250M0.0%
Supernus Pharmaceuticals logo
Supernus PharmaceuticalsSUPN
130M0.0%
Theravance Biopharma logo
Theravance BiopharmaTBPH
$1K0.0%

Other financials

Income statement

See full
Revenue$193.5M+8.9%
Gross profit$117.2M+20.5%
Operating income$30.9M+42.5%
Net income$14.5M+500%
EPS (diluted)$0.40+471%

Balance sheet

See full
Cash & equivalents$289.6M+147%
Total debt$5.2M-19.5%
Total equity$312.4M+33.3%
Total assets$1.7B+1.3%

Cash flow

See full
Operating cash flow$57.1M+3.1%
CapEx$270.0K-66.2%
Free cash flow$56.8M+4.1%

Valuation

See full
Market cap$1.15B+20.4%
Enterprise value$869.67M+2.5%
P/E15.4×-6.4×
P/S1.5×0.0×

Profitability

See full
Gross margin60.7%+3.0pp
Operating margin23.7%+2.3pp
Net margin9.4%+2.8pp
FCF margin41.4%+10.4pp

Returns & leverage

See full
Return on equity27.4%+8.2pp
Debt / equity0.0×
Current ratio1.7×+0.6×

Where this comes from

Reported directly by Collegium Pharmaceutical, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.

The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Collegium Pharmaceutical, Inc.'s common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s common stock?
Collegium Pharmaceutical, Inc. (COLL) reported common stock of 100M in Q1 2026.
How has Collegium Pharmaceutical, Inc.'s common stock changed year-over-year?
Collegium Pharmaceutical, Inc.'s common stock increased by 249900.0% year-over-year, from 40K to 100M.
What is the long-term trend for Collegium Pharmaceutical, Inc.'s common stock?
Over 5 years (2020 to 2025), Collegium Pharmaceutical, Inc.'s common stock has grown at a 391.1% compound annual growth rate (CAGR), from 35K to 100M.
What does common stock mean?
The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).